NCT04696328View on ClinicalTrials.gov

Clinical Trial of Human (Allogeneic) iPS Cell-derived Cardiomyocytes Sheet for Ischemic Cardiomyopathy

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 2, 2019

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2023

Conditions
Myocardial Ischemia
Interventions
BIOLOGICAL

Human (allogeneic) iPS cell derived-cardiomyocyte sheet

Transplantation

Trial Locations (1)

5650871

RECRUITING

Osaka University Hospital, Suita

Sponsors

Collaborators (1)

Cuorips Inc.
All Listed Sponsors
collaborator

Cuorips Inc.

UNKNOWN

lead

Osaka University

OTHER